These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 18346639)

  • 1. TNFalpha in patients with end-stage heart failure on medical therapy or supported by a left ventricular assist device.
    Bruggink AH; van Oosterhout MF; De Jonge N; Gmelig-Meyling FH; De Weger RA
    Transpl Immunol; 2008 Apr; 19(1):64-8. PubMed ID: 18346639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteopontin: a potential biomarker for heart failure and reverse remodeling after left ventricular assist device support.
    Schipper ME; Scheenstra MR; van Kuik J; van Wichen DF; van der Weide P; Dullens HF; Lahpor J; de Jonge N; De Weger RA
    J Heart Lung Transplant; 2011 Jul; 30(7):805-10. PubMed ID: 21531579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device.
    Bruggink AH; de Jonge N; van Oosterhout MF; Van Wichen DF; de Koning E; Lahpor JR; Kemperman H; Gmelig-Meyling FH; de Weger RA
    J Heart Lung Transplant; 2006 Feb; 25(2):174-80. PubMed ID: 16446217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-alpha promoter polymorphisms and the risk of rejection after liver transplantation: a case control analysis of 210 donor-recipient pairs.
    Jazrawi SF; Zaman A; Muhammad Z; Rabkin JM; Corless CL; Olyaei A; Biggs A; Ham J; Chou S; Rosen HR
    Liver Transpl; 2003 Apr; 9(4):377-82. PubMed ID: 12682890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF-alpha gene promoter polymorphism at nucleotide -308 and the inflammatory response and oxidative stress induced by cardiac surgery: role of heart failure and medical treatment.
    Galiñanes M; James M; Codd V; Baxi A; Hadjinikolaou L
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):332-7. PubMed ID: 18450464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alleles -308A and -1031C in the TNF-alpha gene promoter do not increase the risk but associated with circulating levels of TNF-alpha and clinical features of vivax malaria in Indian patients.
    Sohail M; Kaul A; Bali P; Raziuddin M; Singh MP; Singh OP; Dash AP; Adak T
    Mol Immunol; 2008 Mar; 45(6):1682-92. PubMed ID: 17996942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the -308 tumor necrosis factor-alpha promoter gene.
    Ho SY; Wang YJ; Chen HL; Chen CH; Chang CJ; Wang PJ; Chen HH; Guo HR
    Cancer Causes Control; 2004 Sep; 15(7):657-63. PubMed ID: 15280623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism in patients with end-stage renal failure.
    Shu KH; Cheng CH; Wu MJ; Chen CH; Lee WC
    Ren Fail; 2005; 27(1):53-7. PubMed ID: 15717635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties.
    Klotz S; Barbone A; Reiken S; Holmes JW; Naka Y; Oz MC; Marks AR; Burkhoff D
    J Am Coll Cardiol; 2005 Mar; 45(5):668-76. PubMed ID: 15734609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association between the -308 polymorphism of the tumor necrosis factor-alpha gene and the insulin resistance syndrome.
    da Sliva B; Gapstur SM; Achenbach YH; Schuh TS; Kotlar TJ; Liu K; Lowe WL
    J Investig Med; 2000 Jul; 48(4):236-44. PubMed ID: 10916281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome and bridge to transplant rate of left ventricular assist device recipient patients: comparison between continuous-flow and pulsatile-flow devices.
    Garatti A; Bruschi G; Colombo T; Russo C; Lanfranconi M; Milazzo F; Frigerio M; Vitali E
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):275-80; discussion 280. PubMed ID: 18375138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable left ventricular assist devices: new hope for patients with end-stage heart failure.
    Milano CA; Lodge AJ; Blue LJ; Smith PK; Felker GM; Hernandez AF; Rosenberg PB; Rogers JG
    N C Med J; 2006; 67(2):110-5. PubMed ID: 16752713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial insulin-like growth factor-I gene expression during recovery from heart failure after combined left ventricular assist device and clenbuterol therapy.
    Barton PJ; Felkin LE; Birks EJ; Cullen ME; Banner NR; Grindle S; Hall JL; Miller LW; Yacoub MH
    Circulation; 2005 Aug; 112(9 Suppl):I46-50. PubMed ID: 16159864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term mechanical unloading and reverse remodeling of failing hearts in children.
    Mohapatra B; Vick GW; Fraser CD; Clunie SK; Towbin JA; Sinagra G; Vatta M
    J Heart Lung Transplant; 2010 Jan; 29(1):98-104. PubMed ID: 19783184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in regulatory microRNA expression in myocardium of heart failure patients on left ventricular assist device support.
    Schipper ME; van Kuik J; de Jonge N; Dullens HF; de Weger RA
    J Heart Lung Transplant; 2008 Dec; 27(12):1282-5. PubMed ID: 19059107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does continuous flow left ventricular assist device technology have a positive impact on outcome pretransplant and posttransplant?
    Klotz S; Stypmann J; Welp H; Schmid C; Drees G; Rukosujew A; Scheld HH
    Ann Thorac Surg; 2006 Nov; 82(5):1774-8. PubMed ID: 17062246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of genetic variation of tumor necrosis factor-alpha on gestational hypertension.
    Chen YP; Pfab T; Slowinski T; Richter CM; Godes M; Hocher B
    Chin Med J (Engl); 2006 May; 119(9):719-24. PubMed ID: 16701011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of recurrent heart failure associated with left ventricular assist device dysfunction.
    Jaski BE; Miller DA; Hoagland PM; Gordon JB; Chillcott SR; Stahovich MJ; Adamson RM; Baradarian S; Dembitsky WP
    J Heart Lung Transplant; 2005 Dec; 24(12):2060-7. PubMed ID: 16364850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics of humoral and cytokine activation in heart failure and its importance for risk stratification of patients.
    Spinarová L; Spinar J; Vasků A; Pávková-Goldbergová M; Ludka O; Tomandl J; Vítovec J
    Exp Mol Pathol; 2008 Jun; 84(3):251-5. PubMed ID: 18442814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma neurohormone levels correlate with left ventricular functional and morphological improvement in LVAD patients.
    Thompson LO; Skrabal CA; Loebe M; Lafuente JA; Roberts RR; Akgul A; Jones V; Bruckner BA; Thohan V; Noon GP; Youker KA
    J Surg Res; 2005 Jan; 123(1):25-32. PubMed ID: 15652947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.